Media OutReach
Hong Kong Baptist University and Elsevier Report Highlights Global Expansion of Chinese Medicine Research, Urges Standardised Frameworks for Broader Integration

Key findings from the report include:
- Rapid expansion: Chinese Medicine research grew at a 10.6% compound annual growth rate — more than double the global research average — nearly tripling output between 2014 and 2023.
- High scholarly impact: 14.2% of Chinese Medicine papers ranked among the world’s top 10% most-cited (global norm: 10%), with a field-weighted citation impact (FWCI) of 1.12.
- Interdisciplinary breadth: Medicine dominates (61.9% of output), followed by Biochemistry, Genetics & Molecular Biology (33.1%) and Pharmacology (28.1%). Citing publications span diverse major domains — from Engineering to Materials Science.
- Global collaboration hubs: Hong Kong SAR and Macao SAR exceed 80% cross-regional collaboration, above the 18% world average, and achieving FWCI >1.6 in cross-regional collaborative publications.
- Emerging research foci: Top-published trending topics include “Herbaceous Agent | Chinese Medicine | Network Pharmacology” and COVID-19 applications, reflecting integration of omics, AI and systems methods.
- Societal resonance: 11.1% of research outputs were mentioned on social media and 2.9% cited in policy documents, reflecting growing public and policymaker interest.
Bridging a global integration gap
Chinese Medicine’s mainstream integration lacks a global, transparent, evidence-based framework. To elevate its scientific profile, key strategies include developing internationally accepted clinical guidelines through expert consensus, enhancing trial reporting standards to improve research quality, and fostering interdisciplinary, cross-regional collaboration to drive innovation and systemic impact.
“‘Evolving Legacy’ demonstrates how Chinese Medicine research has matured into a global, evidence-informed field,” said Professor Lyu Aiping, Vice-President (Research & Development), HKBU, and a leading expert in Chinese Medicine. “We envision a future where data science and AI illuminate what Chinese Medicine research has long intimated, providing deeper insights into health classifications and compound interventions. The next frontier is using Chinese Medicine research to uncover insights possibly overlooked in Digital Health and Systems Medicine, strengthening their scientific foundation and impact.”
“This report offers unprecedented insights into Chinese Medicine’s evolving scientific landscape,” added Basak Candemir, Business Development Director, Analytical and Data Services, Elsevier. “It illuminates the growing global impact of Chinese Medicine research and its role in diversified healthcare solutions, making a vital step towards bridging traditional knowledge with modern validation for the benefit of global health.”
The report was developed using Elsevier’s bibliometric tools, Scopus and SciVal, based on a comprehensive dataset and case studies compiled in collaboration with HKBU Chinese Medicine research experts. The report can be accessed on https://cm-evaluation.scm.hkbu.edu.hk/.
Hashtag: #HKBU
The issuer is solely responsible for the content of this announcement.
Media OutReach
From Differentiation to Emotional Connection: 180 Brand Talk 6.0 Returns to Help Brands Win Hearts

- Many SMEs start by asking how to make customers choose their brand.
- But the real question is—if customers don’t like a brand, there’s no reason for them to choose it.
KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 18 August 2025 – To break through this challenge, it all comes down to one thing: building an emotional connection that wins hearts.
Brand positioning means that when customers encounter a problem, they immediately think of that brand. This can’t be achieved simply by spending on ads—it takes the right approach to make that brand truly resonate.
Addressing the pain points and blind spots of SMEs, Chan Fong has hosted five editions of 180 Brand Talk over the past three years, helping hundreds of businesses uncover their unique points of differentiation and build a brand positioning that is distinctly their own.
This session’s speaker, Chan Fong, is not only a well-known radio DJ but also a veteran advertising professional with 28 years of experience who, together with the team at 180 Degrees Brandcom, has spent more than two decades rebranding renowned brands such as OGAWA, CUCKOO, EcoWorld, Knife, BRAND’s and more, as well as guiding countless SMEs from the ground up to establish a solid foundation and define their positioning.
“Managing a brand isn’t about creating demand, but recognising it,” Chan Fong emphasises. A brand that truly wins hearts always has a clear image, a distinctive personality, and well-defined differentiation.
From long-term observations, Chan Fong found that about 70–80% of SMEs in Malaysia are run by the Chinese community, yet many of these brands lack an emotional connection with consumers. Even with strong and distinctive points of differentiation, they often struggle to communicate them effectively due to the wrong approach. To address this, Chan Fong launched the 180 Brand Talk programme, drawing on practical experience to guide SMEs in defining their brand positioning and building emotional connections.
What Makes This Programme Stand Out
In the 180 Brand Talk programme, Chan Fong avoids abstract theories and marketing jargon. Drawing on 28 years of hands-on experience, the programme shares numerous local case studies that reflect the real challenges faced by Malaysian SMEs, enabling entrepreneurs to relate easily and apply the lessons learned. The programme also features dedicated discussion sessions with the 180 team, where participants can present their brand’s pain points and receive practical, actionable advice.
Whether they are new entrepreneurs taking their first steps or seasoned brand owners stuck at a standstill, this programme helps businesses find their next breakthrough.
From Differentiation to Emotional Connection: 180 Brand Talk 6.0 Programme Details:
Date: 9–10 September 2025 (Tuesday–Wednesday)
Time: 10:00am–6:00pm
Venue: Courtyard by Marriott KL South
Remark: This programme is recognised under Malaysia’s Human Resources Development Fund (HRDF). Eligible companies may apply for HRDF reimbursement claims.
Special Offer:
Register now and use promo code TN200 to enjoy an RM200 discount per ticket! Limited seats are available—first come, first served.
Registration link: https://givingtreeglobal.com/upcoming-event/chan-fong-brand-talk/
Hashtag: #180BrandingStrategicGuideline #branding #brandtalk6.0 #BrandStrategy #BuildYourBrand #BrandVision #BrandPositioning #BrandDifferentiation
https://www.180.com.my/
https://www.facebook.com/180DegreesBrandcom
https://www.instagram.com/180degreesbrandcom/
The issuer is solely responsible for the content of this announcement.
Media OutReach
HOPE Foundation and Taiwan’s Top Lung Cancer Experts Call for Seamless Integration of Early Screening, Precision Diagnostics, and Early Treatment
Taiwan’s proactive approach to lung cancer prevention is recognized globally for its vision and effectiveness. In July 2022, the government launched the Lung Cancer Early Detection Program, offering biannual low-dose CT (LDCT) screenings for high-risk groups, including those with a family history of lung cancer and heavy smokers. This pioneering initiative has positioned Taiwan as an international role model in lung cancer prevention. Over the past three years, more than 210,000 screenings have led to the identification of 2,506 lung cancer cases—over 80% of which were diagnosed at an early stage, with late-stage diagnoses dropping sevenfold. Previously, late-stage diagnosis was the norm, but Taiwan’s proactive policies have transformed the landscape, reversing the trend and ensuring that most initial lung cancer cases are now detected early.

During his recent visit to Taiwan, Dr. Cary Adams, CEO of the Union for International Cancer Control (UICC), commended Taiwan’s National Cancer Control Program, its comprehensive cancer registry, and robust National Health Insurance (NHI) system for establishing an exemplary cancer care network. He encouraged Taiwan to further improve early lung cancer screening rates and timely access to treatment, reinforcing its status as a global public health leader. At the conference, Minister of Health and Welfare Dr. Chiu Tai-Yuan pledged ongoing cross-ministerial collaboration and policy innovation to improve early lung cancer detection and treatment. Legislator Wang Cheng-Hsu also reaffirmed his commitment to early detection and intervention, advocating for increased resources and improved legislation to ensure early-stage lung cancer patients receive comprehensive care.
Leading medical experts further emphasized Taiwan’s advancements. Dr. Yang, Pan-Chyr, Academician of Academia Sinica, highlighted how the LDCT screening program has driven a shift toward earlier-stage diagnosis, with research indicating it could reduce lung cancer mortality by 53%. Dr. Chen Chien-Jen, Academician of Academia Sinica emphasized that the next key challenge is ensuring early-stage patients benefit from precision diagnostics and early treatment. Dr. Yang Cheng-Ta, President of the Taiwan Lung Cancer Society, added that emerging AI technology is now capable of analyzing LDCT images to predict an individual’s six-year cancer risk, which will improve identification of high-risk groups and support early intervention. Dr. Yang Chih-Hsin, President of Taiwan Association for the Study of Lung Cancer, urged early-stage patients to undergo genetic testing promptly, enabling medical teams to tailor optimal treatment plans, including surgery, targeted therapy, or immunotherapy as adjuvant treatments.
HOPE called for NHI resources to shift toward early lung cancer diagnosis and treatment, highlighting the importance of genetic testing and adjuvant therapy for high-risk early-stage patients to reduce relapse and mortality. Clinical evidence shows that adjuvant targeted therapy after surgery for stage IB–IIIA lung cancer with EGFR mutations can reduce five-year mortality by 10%, which is vital for improving outcomes and easing the burden on the healthcare system. Dr. Chen Jin-Shing, Head of Thoracic Surgery Division at National Taiwan University Hospital, advocated for priority reimbursement of adjuvant targeted therapy for patients with stage IB-IIIA lung cancer, while Dr. Chen Chih-Yi, Board Member of HOPE emphasized the importance of improving access to early genetic testing and treatment. Dr. Huang, Ming-Shyan, President of the Taiwan Clinical Oncology Society, pointed out that early-stage lung cancer treatment in Taiwan is not yet fully aligned with international guidelines, and urged that expanded screening must be matched with optimized NHI resource allocation and improved treatment access.
Other leading voices reinforced the need for comprehensive care. Dr. Wang Chin-Chou, Board Member of Taiwan Society of Pulmonary and Critical Care Medicine, stressed that while surgery is the primary treatment for early-stage lung cancer, it must be accompanied by proactive adjuvant therapy strategies and long-term follow-up. Dr. Chang Wen-Cheng, CEO of Taiwan Cancer Foundation emphasized that the integration of screening, diagnosis, and treatment is crucial to truly realize early detection and treatment, as well as maximizing the value of screening program. Dr. Chen Jen-Shi, President of Taiwan Oncology Society, recommended that in addition to current NHI and Cancer Drug Fund financing, the government should promote diverse payment mechanisms—such as co-payment models or commercial insurance to supplement the NHI system—to further improve access to early lung cancer treatment.
Uniting multiple lung cancer treatment experts from medical centers across Taiwan, a concerted effort to usher in a new era of early lung cancer screening and treatment. (Listed by institution from North to South)
· Dr. Chen Yu-Min, Director of General Chest Medicine Department, Taipei Veterans General Hospital
· Dr. Lee Kang-Yun, Attending Physician, Division of Pulmonary Medicine, Shuang Ho Hospital
· Dr. Huang Chun-Yao, Attending Physician, Division of Chest Medicine, Taipei Tzu Chi Hospital
· Dr. Tsai Chen-Liang, Director of Pulmonary and Critical Care Medicine Division, Tri-Service General Hospital
· Dr. Yeh Yu-Wen, Physician, Division of Thoracic Medicine, Shin Kong Wu Ho-Su Memorial Hospital
· Dr. Chang Sheng-Yu, Attending Physician and Leader of the Lung Cancer Team, Far Eastern Memorial Hospital
· Dr. Yang Tsung-Ying, Director of General Chest Medicine Department, Taichung Veterans General Hospital
· Dr. Hsia Te-Chun, Deputy Director, Department of Internal Medicine, China Medical University Hospital
· Dr. Lin Chien-Chung, Attending Physician, Division of Chest Medicine, National Cheng Kung University Hospital
Hashtag: #HOPEFoundation
The issuer is solely responsible for the content of this announcement.
Media OutReach
GWM Brazil Plant Officially Opens with President Lula in Attendance

This milestone not only advances GWM’s globalization in Latin America but also sets an example of China’s high-quality automotive expansion, showcasing innovative collaboration between the Chinese and Brazilian auto industries.
At the opening ceremony, Brazilian President Luiz Inácio Lula da Silva, Vice President Geraldo Alckmin, Chinese Ambassador Zhu Qingqiao, Brazil’s Minister of Labor, and other dignitaries joined GWM President Mu Feng, GWM International President Parker Shi, GWM Brazil Region President Zhang Gengshen, and other GWM executives to witness this landmark moment in the company’s globalization journey. President Lula personally signed the hood of the first HAVAL H6 GT, marking its final production step before entering the market. After the ceremony, he also posed for photos with factory workers.
In his welcome address, GWM President Mu Feng stated: “The Brazil plant is not only a strong commitment to the Brazilian market, but also the starting point for building the future together with our Latin American partners. In our global expansion, we adhere to the ‘Four New Modernizations’: Locally Built, Locally Operated, Globally Cultivated, Supply Chain Integrated. Following international quality standards, we will deliver highly reliable vehicles to the Latin American market.” He further announced that the plant’s annual production capacity will gradually increase from 20,000 to 50,000 vehicles, creating over 1,000 direct jobs. Initial models include the HAVAL H9, POER P30, and HAVAL H6, with the H9 and POER P30 scheduled to launch in Brazil this September.
Chinese Ambassador Zhu Qingqiao emphasized that since the establishment of diplomatic ties 51 years ago, China and Brazil’s comprehensive strategic partnership has continued to deepen, with key areas of cooperation including renewable energy, infrastructure, and manufacturing. He described the Brazil plant as a model of Sino-Brazilian industrial synergy, combining “Chinese smart manufacturing + Brazilian localization.” He noted that GWM is contributing to economic development and quality job creation in São Paulo and Brazil, and expressed hope for further collaboration in clean energy and digital technology to provide a “China-Brazil solution” for global climate governance.
In his speech, President Lula stressed: “The GWM Brazil plant is very important for Brazil’s national industry. Its inauguration shows that Brazil has the capability to acquire advanced technology and produce vehicles that can compete with those from any country in the world. This means creating jobs, increasing income, and enhancing professional expertise for Brazilians. We hope GWM will make Brazil its production base in Latin America. The Brazilian government stands ready to support businesses and welcomes more Chinese companies to invest here.”
Brazilian Vice President Alckmin, the Minister of Labor, and the Mayor of Iracemápolis also gave speeches, jointly opening a new chapter for GWM in Latin America. Guests at the ceremony praised GWM’s rapid growth and contributions to Brazil’s automotive market and expressed confidence in the company’s ability to further drive innovation and transformation in the industry. During the event, the Great Place to Work Institute awarded GWM Brazil the “Great Place To Work” (GPTW) honor. In addition, GWM announced a donation of 500,000 reais to local schools in Iracemápolis to help improve educational facilities.
Located in Iracemápolis, São Paulo, the GWM Brazil plant covers a total area of 1.2 million square meters, with 94,000 square meters of built-up area. It houses welding workshops, robotic painting lines, assembly lines, energy and equipment facilities, and logistics supply systems. With an initial annual production capacity of 50,000 vehicles, the plant is expected to create 1,000 jobs by the end of this year. Initial models will include the HAVAL H9, POER P30, and the HAVAL H6 series. The plant also supports flexible production of multiple energy types, including hybrid (HEV), plug-in hybrid (PHEV), and diesel.
Since entering the Brazilian market in 2021, GWM has reached annual sales of 29,000 units within just three years, ranking 14th in the market. In the first half of this year, GWM sold over 15,700 vehicles in Brazil, up 19.8% year-on-year—17 percentage points above the industry average—demonstrating the company’s confidence and determination to expand overseas and compete globally.
Rooted in Brazil, expanding across Latin America, and reaching the world, GWM will continue to invest in Brazil, focusing on quality jobs, technological leadership, and R&D. The opening of the Brazil plant marks a new chapter in Chinese automotive globalization. With this plant, GWM will strengthen localized smart manufacturing, deepen its presence in Latin America, and bring its products and services to more global markets.
Hashtag: #GWM
The issuer is solely responsible for the content of this announcement.
-
Feature/OPED6 years ago
Davos was Different this year
-
Travel/Tourism9 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz3 years ago
Estranged Lover Releases Videos of Empress Njamah Bathing
-
Banking7 years ago
Sort Codes of GTBank Branches in Nigeria
-
Economy2 years ago
Subsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking2 years ago
First Bank Announces Planned Downtime
-
Sports2 years ago
Highest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn
-
Technology5 years ago
How To Link Your MTN, Airtel, Glo, 9mobile Lines to NIN